Skip to main content

Advertisement

SpringerLink
Log in

Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?

  • Urology - Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

The role of metastasectomy on survival in advanced/urologic malignancies still remains unclear. Renal cell carcinoma (RCC) is the most common solid tumor within the kidney. 25–30 % of patients have metastases at manifestation. Urothelial carcinoma (UC) consists of bladder carcinoma, upper urinary tract urothelial cell carcinoma and urethral carcinoma. Bladder cancer is the ninth most common cancer worldwide. Half of patients with muscle invasive bladder cancer have lymph node or distant metastases. In metastatic disease first-line treatment is multi-agent platinum-based systemic chemotherapy. Testicular cancer is the most common cancer in men between the age of 15 and 35. Testicular tumors represent excellent oncologic outcomes. Prostate cancer is the most common solid tumor in Europe. Surgical resection of metastases can be considered as a treatment choice in advanced/metastatic urologic malignancies to improve survival rates, particularly in RCC and UC. Metastasectomy can be suggested in conjunction with effective chemotherapy if complete resection is possible. Solitary metastasectomy can represent better survival rates compared to multiple metastasectomy even if multiple metastases confined to single organ. Site of metastases is one of the main determinants of successful metastasectomy such as lung metastasectomy in urothelial cell carcinoma and liver metastasectomy in RCC may lead to better oncologic outcomes. Due to the lack of the relevant data it is not possible to make an evidence-based recommendation on the role of metastasectomy for solitary-/organ-confined metastases of prostate cancer, testicular cancer and penile cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. doi:10.1016/j.eururo.2015.01.005

    Article  PubMed  Google Scholar 

  2. Swanson DA (2004) Surgery for metastases of renal cell carcinoma. Scand J Surg 93(2):150–155

    CAS  PubMed  Google Scholar 

  3. Mekhail TM, Abou-Jawde RM, Boumerhi G, Malhi S, Wood L, Elson P, Bukowski R (2005) Validation and extension of the memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. J Clin Oncol 23(4):832–841. doi:10.1200/JCO.2005.05.179

    Article  PubMed  Google Scholar 

  4. Tanis PJ, van der Gaag NA, Busch OR, van Gulik TM, Gouma DJ (2009) Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Brit J Surg 96(6):579–592. doi:10.1002/bjs.6606

    Article  CAS  PubMed  Google Scholar 

  5. Thyavihally YB, Mahantshetty U, Chamarajanagar RS, Raibhattanavar SG, Tongaonkar HB (2005) Management of renal cell carcinoma with solitary metastasis. World J Surg Oncol 3:48. doi:10.1186/1477-7819-3-48

    Article  PubMed  PubMed Central  Google Scholar 

  6. Pomer S, Klopp M, Steiner HH, Brkovic D, Staehler G, Cabillin-Engenhart R (1997) Brain metastases in renal cell carcinoma. Results of treatment and prognosis. Der Urologe Ausg A 36(2):117–125

    Article  CAS  PubMed  Google Scholar 

  7. Martinez Ruiz J, Ruiz Mondejar R, Carrion Lopez P, Martinez Sanchiz C, Donate Moreno MJ, Pastor Navarro H, Peran Teruel M, Virseda Rodriguez JA (2011) Vaginal metastasis of a clear renal cell carcinoma. Arch Esp Urol 64(4):380–383

    PubMed  Google Scholar 

  8. Matsumoto K, Hayakawa N, Nakamura S, Oya M (2015) Bladder metastasis from renal cell carcinoma: retrospective analysis of 65 reported cases. Clin Exp Metastasis 32(2):135–141. doi:10.1007/s10585-015-9698-1

    Article  CAS  PubMed  Google Scholar 

  9. Tolia BM, Whitmore WF Jr (1975) Solitary metastasis from renal cell carcinoma. J Urol 114(6):836–838

    CAS  PubMed  Google Scholar 

  10. Kozlowski JM (1994) Management of distant solitary recurrence in the patient with renal cancer. Contralateral kidney and other sites. Urol Clin N Am 21(4):601–624

    CAS  Google Scholar 

  11. van der Poel HG, Roukema JA, Horenblas S, van Geel AN, Debruyne FM (1999) Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 35(3):197–203

    Article  PubMed  Google Scholar 

  12. Staehler MD, Kruse J, Haseke N, Stadler T, Roosen A, Karl A, Stief CG, Jauch KW, Bruns CJ (2010) Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol 28(4):543–547. doi:10.1007/s00345-010-0560-4

    Article  PubMed  Google Scholar 

  13. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE (2005) Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 48 (1):77–81; discussion 81–72. doi:10.1016/j.eururo.2005.03.004

  14. Hatzaras I, Gleisner AL, Pulitano C, Sandroussi C, Hirose K, Hyder O, Wolfgang CL, Aldrighetti L, Crawford M, Choti MA, Pawlik TM (2012) A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer. HPB 14(8):532–538. doi:10.1111/j.1477-2574.2012.00495.x

    Article  PubMed  PubMed Central  Google Scholar 

  15. Antonelli A, Arrighi N, Corti S, Legramanti S, Zanotelli T, Cozzoli A, Cunico SC, Simeone C (2012) Surgical treatment of atypical metastasis from renal cell carcinoma (RCC). BJU Int 110(11 Pt B):E559–E563. doi:10.1111/j.1464-410X.2012.11271.x

    Article  PubMed  Google Scholar 

  16. Baloch KG, Grimer RJ, Carter SR, Tillman RM (2000) Radical surgery for the solitary bony metastasis from renal-cell carcinoma. J Bone Joint Surg Brit 82(1):62–67

    Article  CAS  PubMed  Google Scholar 

  17. Sellner F, Tykalsky N, De Santis M, Pont J, Klimpfinger M (2006) Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. Ann Surg Oncol 13(1):75–85. doi:10.1245/ASO.2006.03.064

    Article  PubMed  Google Scholar 

  18. Sohn TA, Yeo CJ, Cameron JL, Nakeeb A, Lillemoe KD (2001) Renal cell carcinoma metastatic to the pancreas: results of surgical management. J Gastrointest Surg 5(4):346–351

    Article  CAS  PubMed  Google Scholar 

  19. Benhaim R, Oussoultzoglou E, Saeedi Y, Mouracade P, Bachellier P, Lang H (2015) Pancreatic metastasis from clear cell renal cell carcinoma: outcome of an aggressive approach. Urology 85(1):135–140. doi:10.1016/j.urology.2014.09.034

    Article  PubMed  Google Scholar 

  20. Kim DY, Karam JA, Wood CG (2014) Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy. World J Urol 32(3):631–642. doi:10.1007/s00345-014-1293-6

    Article  PubMed  Google Scholar 

  21. Karam JA, Rini BI, Varella L, Garcia JA, Dreicer R, Choueiri TK, Jonasch E, Matin SF, Campbell SC, Wood CG, Tannir NM (2011) Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma. J Urol 185(2):439–444. doi:10.1016/j.juro.2010.09.086

    Article  PubMed  PubMed Central  Google Scholar 

  22. Ljungberg B (2013) The role of metastasectomy in renal cell carcinoma in the era of targeted therapy. Curr Urol Rep 14(1):19–25. doi:10.1007/s11934-012-0293-6

    Article  PubMed  Google Scholar 

  23. Roupret M, Babjuk M, Comperat E, Zigeuner R, Sylvester RJ, Burger M, Cowan NC, Bohle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF (2015) European association of urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update. Eur Urol. doi:10.1016/j.eururo.2015.06.044

    Google Scholar 

  24. Witjes JA, Comperat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A, European Association of U (2014) EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 65(4):778–792. doi:10.1016/j.eururo.2013.11.046

    Article  PubMed  Google Scholar 

  25. Yafi FA, Kassouf W (2009) Management of patients with advanced bladder cancer following major response to systemic chemotherapy. Expert Rev Anticancer Ther 9(12):1757–1764. doi:10.1586/era.09.148

    Article  PubMed  Google Scholar 

  26. Abe T, Shinohara N, Harabayashi T, Sazawa A, Maruyama S, Suzuki S, Nonomura K (2007) Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol 52(4):1106–1113. doi:10.1016/j.eururo.2007.02.052

    Article  PubMed  Google Scholar 

  27. Siefker-Radtke AO, Walsh GL, Pisters LL, Shen Y, Swanson DA, Logothetis CJ, Millikan RE (2004) Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. J Urol 171(1):145–148. doi:10.1097/01.ju.0000099823.60465.e6

    Article  PubMed  Google Scholar 

  28. Lehmann J, Suttmann H, Albers P, Volkmer B, Gschwend JE, Fechner G, Spahn M, Heidenreich A, Odenthal A, Seif C, Nurnberg N, Wulfing C, Greb C, Kalble T, Grimm MO, Fieseler CF, Krege S, Retz M, Schulte-Baukloh H, Gerber M, Hack M, Kamradt J, Stockle M (2009) Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05). Eur Urol 55(6):1293–1299. doi:10.1016/j.eururo.2008.11.039

    Article  PubMed  Google Scholar 

  29. Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J, Nishimura K, Kodama K (2010) Outcome of surgical resection of pulmonary metastasis from urinary tract transitional cell carcinoma. Interact CardioVasc Thorac Surg 11(1):60–64. doi:10.1510/icvts.2010.236687

    Article  PubMed  Google Scholar 

  30. Otto T, Krege S, Suhr J, Rubben H (2001) Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial. Urology 57(1):55–59

    Article  CAS  PubMed  Google Scholar 

  31. Gallagher HJ, Redmond HP, Deasy J, McLean PA (1998) Hepatic resection of solitary metastasis from transitional cell carcinoma of the bladder. J Urol 159(3):986

    Article  CAS  PubMed  Google Scholar 

  32. Kim T, Ahn JH, You D, Jeong IG, Hong B, Hong JH, Ahn H, Lee JL (2015) Pulmonary metastasectomy could prolong overall survival in select cases of metastatic urinary tract cancer. Clin Genitourin Cancer 13(4):e297–e304. doi:10.1016/j.clgc.2015.04.013

    Article  PubMed  Google Scholar 

  33. Zigouris A, Pahatouridis D, Mihos E, Alexiou GA, Nesseris J, Zikou AK, Argyropoulou MI, Goussia A, Voulgaris S (2009) Solitary cystic cerebral metastasis from transitional cell carcinoma of the bladder. Acta Neurol Belg 109(4):322–325

    PubMed  Google Scholar 

  34. Vaa B, Kohli M, Price KA, Swetz KM (2014) Solitary cystic cerebellar metastasis in a patient with invasive transitional cell carcinoma of the bladder. BMJ Case Reports. doi:10.1136/bcr-2013-200137

    PubMed  Google Scholar 

  35. Protzel C, Zimmermann U, Asse E, Kallwellis G, Klebingat KJ (2002) Gemcitabine and radiotherapy in the treatment of brain metastases from transitional cell carcinoma of the bladder: a case report. J Neurooncol 57(2):141–145

    Article  PubMed  Google Scholar 

  36. Shamdas GJ, McLaren GD, Grimm T, Everson LK (1992) Solitary cerebellar metastasis from transitional cell carcinoma of bladder. Urology 40(1):50–53

    Article  CAS  PubMed  Google Scholar 

  37. Nonomura N, Nagahara A, Oka D, Mukai M, Nakai Y, Nakayama M, Nishimura K, Kakimoto K, Nakamura T, Usami M, Okuyama A, Miki T (2009) Brain metastases from testicular germ cell tumors: a retrospective analysis. Int J Urol 16(11):887–893. doi:10.1111/j.1442-2042.2009.02391.x

    Article  PubMed  Google Scholar 

  38. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP, European Association of U (2011) EAU guidelines on testicular cancer: 2011 update. Eur Urol 60(2):304–319. doi:10.1016/j.eururo.2011.05.038

    Article  PubMed  Google Scholar 

  39. Copson E, McKendrick J, Hennessey N, Tung K, Mead GZ (2004) Liver metastases in germ cell cancer: defining a role for surgery after chemotherapy. BJU Int 94(4):552–558. doi:10.1111/j.1464-410X.2004.04999.x

    Article  PubMed  Google Scholar 

  40. Heidenreich A (2007) Residual tumour resection following inductive chemotherapy in advanced testicular cancer. Eur Urol 51(2):299–301. doi:10.1016/j.eururo.2006.06.046

    Article  PubMed  Google Scholar 

  41. International Germ Cell Cancer Collaborative Group (1997) International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15(2):594–603

    Google Scholar 

  42. Salvati M, Piccirilli M, Raco A, Santoro A, Frati R, Lenzi J, Lanzetta G, Agrillo A, Frati A (2006) Brain metastasis from non-seminomatous germ cell tumors of the testis: indications for aggressive treatment. Neurosurg Rev 29(2):130–137. doi:10.1007/s10143-005-0004-6

    Article  PubMed  Google Scholar 

  43. Bindal RK, Sawaya R, Leavens ME, Lee JJ (1993) Surgical treatment of multiple brain metastases. J Neurosurg 79(2):210–216. doi:10.3171/jns.1993.79.2.0210

    Article  CAS  PubMed  Google Scholar 

  44. Iwadate Y, Namba H, Yamaura A (2000) Significance of surgical resection for the treatment of multiple brain metastases. Anticancer Res 20(1B):573–577

    CAS  PubMed  Google Scholar 

  45. Mahalati K, Bilen CY, Ozen H, Aki FT, Kendi S (1999) The management of brain metastasis in nonseminomatous germ cell tumours. BJU Int 83(4):457–461

    Article  CAS  PubMed  Google Scholar 

  46. Rees GM, Cleland WP (1971) Surgical treatment of pulmonary metastases from testicular tumours. Br Med J 3(5772):467–470

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Reed RR, Barry JM, Hodges CV (1976) Testis tumor metastatic to lung: twenty-two-year survivor. Urology 7(3):302–304

    Article  CAS  PubMed  Google Scholar 

  48. Michael H, Lucia J, Foster RS, Ulbright TM (2000) The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol 24(2):257–273

    Article  CAS  PubMed  Google Scholar 

  49. Hahn TL, Jacobson L, Einhorn LH, Foster R, Goulet RJ Jr (1999) Hepatic resection of metastatic testicular carcinoma: a further update. Ann Surg Oncol 6(7):640–644

    Article  CAS  PubMed  Google Scholar 

  50. You YN, Leibovitch BC, Que FG (2009) Hepatic metastasectomy for testicular germ cell tumors: is it worth it? J Gastrointest Surg 13(4):595–601. doi:10.1007/s11605-009-0807-9

    Article  PubMed  Google Scholar 

  51. Fitzgerald TL, Brinkley J, Banks S, Vohra N, Englert ZP, Zervos EE (2014) The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbeck’s Arch Surg 399(8):989–1000. doi:10.1007/s00423-014-1241-3

    Article  Google Scholar 

  52. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N, European Association of U (2014) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 65(1):124–137. doi:10.1016/j.eururo.2013.09.046

    Article  PubMed  Google Scholar 

  53. Gandaglia G, Karakiewicz PI, Briganti A, Passoni NM, Schiffmann J, Trudeau V, Graefen M, Montorsi F, Sun M (2015) Impact of the site of metastases on survival in patients with metastatic prostate cancer. Eur Urol 68(2):325–334. doi:10.1016/j.eururo.2014.07.020

    Article  PubMed  Google Scholar 

  54. Hatzoglou V, Patel GV, Morris MJ, Curtis K, Zhang Z, Shi W, Huse J, Rosenblum M, Holodny AI, Young RJ (2014) Brain metastases from prostate cancer: an 11-year analysis in the MRI era with emphasis on imaging characteristics, incidence, and prognosis. J Neuroimagin 24(2):161–166. doi:10.1111/j.1552-6569.2012.00767.x

    Article  Google Scholar 

  55. Castro Gomez JE, Anido Herranz U, Carballo Castro A, Gomez Caamaoo A, Leon Mateos LA, Porto Vazquez C, Lopez Lopez R (2009) Brain metastases from prostate adenocarcinoma. Clin Trans Oncol 11(1):63–64

    Article  CAS  Google Scholar 

  56. Wallis CJ, English JC, Goldenberg SL (2011) The role of resection of pulmonary metastases from prostate cancer: a case report and literature review. Can Urol Assoc J 5(6):E104–E108. doi:10.5489/cuaj.10136

    Article  PubMed  PubMed Central  Google Scholar 

  57. Ratasvuori M, Wedin R, Hansen BH, Keller J, Trovik C, Zaikova O, Bergh P, Kalen A, Laitinen M (2014) Prognostic role of en-bloc resection and late onset of bone metastasis in patients with bone-seeking carcinomas of the kidney, breast, lung, and prostate: SSG study on 672 operated skeletal metastases. J Surg Oncol 110(4):360–365. doi:10.1002/jso.23654

    Article  PubMed  Google Scholar 

  58. Weiss RJ, Forsberg JA, Wedin R (2012) Surgery of skeletal metastases in 306 patients with prostate cancer. Acta orthopaedica 83(1):74–79. doi:10.3109/17453674.2011.645197

    Article  PubMed  PubMed Central  Google Scholar 

  59. Hakenberg OW, Comperat EM, Minhas S, Necchi A, Protzel C, Watkin N, Association E, European Association of U (2015) EAU guidelines on penile cancer: 2014 update. Eur Urol 67(1):142–150. doi:10.1016/j.eururo.2014.10.017

    Article  PubMed  Google Scholar 

  60. Djajadiningrat RS, van Werkhoven E, Horenblas S (2015) Prophylactic pelvic lymph node dissection in patients with penile cancer. J Urol 193(6):1976–1980. doi:10.1016/j.juro.2014.12.019

    Article  PubMed  Google Scholar 

  61. Chalya PL, Rambau PF, Masalu N, Simbila S (2015) Ten-year surgical experiences with penile cancer at a tertiary care hospital in northwestern Tanzania: a retrospective study of 236 patients. World J Surg Oncol 13:71. doi:10.1186/s12957-015-0482-0

    Article  PubMed  PubMed Central  Google Scholar 

  62. Pettaway CA, Pagliaro L, Theodore C, Haas G (2010) Treatment of visceral, unresectable, or bulky/unresectable regional metastases of penile cancer. Urology 76(2 Suppl 1):S58–S65. doi:10.1016/j.urology.2010.03.082

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Hacettepe University School of Medicine, 06100, Sihhiye Ankara, Turkey

    Senol Tonyali & Sertac Yazici

Authors
  1. Senol Tonyali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sertac Yazici
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Senol Tonyali.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interests regarding the publication of this manuscript.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Not required for this type of article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tonyali, S., Yazici, S. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?. Int Urol Nephrol 48, 671–680 (2016). https://doi.org/10.1007/s11255-016-1226-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-016-1226-y

Keywords

Search

Navigation